Cancer immunotherapy has been heralded as paradigm change in cancer treatment. Now, Roche's US arm Genentech announced...
The CHMP elected Harald Enzmann as its new Chair on Friday, and recommended thirteen medicines for approval,...
European stock exchange operator Euronext kicked off its fourth annual capital markets training programme for non-listed...
A new gene drive can cause the complete collapse of caged malaria-carrying mosquito populations, researchers from...
Novo Nordisk A/S (NOVOB:DC) said it plans to restructure its entire Research & Development (R&D) organization....
SIGN UP FOR OUR FREE NEWSLETTER
BACKGROUND
Integrating the disparate stages of drug development is the most time and cost-efficient way of turning a promising...
SERVICE
PRODUCT OF THE WEEK
The new Flexcell® FX-6000 ™ Tension System and other cell...
Dunn Labortechnik will present a variety of cell culture products and the new Flexcell® FX-6000™ Tension System from the American company...
ADVERTORIAL
CYPs have a number of disadvantages, including low stability or inactivity. The Austrian Centre of Industrial Biotechnology (acib), together with an consortium within the...
THE MAG
CURRENT ISSUE
CAR-T cell therapy revs up in Europe
Ever since reports that blood cancer response rates to T cells carrying chimeric antigen receptors (CARs) exceeded 80%, investors have been...
CURRENT SPECIAL
CURRENT ISSUE
CROs & CDMOs
From preclinical development to market approval, biopharma companies increasingly rely on outsourcing to biomanufacturing experts and contract...
SPECIALS
SEE ALL
PEOPLE
APPOINTMENTS
OPINION
Events
UPCOMING EVENTS
IFIB 2018 – International Forum on Industrial Biotechnology and Bioeconomy
27.09.
- 28.09.2018
ǀ Turin (IT)
Cell-Nerf Symposium: Neurotechnologies
30.09.
- 02.10.2018
ǀ Leuven (B)
HUPO 2018
30.09.
- 03.10.2018
ǀ Orlando (USA)
Synthetic Glycobiology
08.10.
- 09.10.2018
ǀ Chicheley (UK)